<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7004624\results\search\disease\results.xml">
  <result pre="Kluwer Health pmid: 31929359CMJ-2019-1321 doi: 10.1097/CM9.000000000000064700009 : Review Articles Human" exact="immunodeficiency" post="virus prevention strategies in China WuZun-You12ScottSarah Robbins1 ChenLi-Min[1], [2],"/>
  <result pre="National Center for AIDS/STD Control and Prevention, Chinese Center for" exact="Disease" post="Control and Prevention, 155 Changbai Road, Changping District, Beijing"/>
  <result pre="Abstract Abstract This paper reviews the current epidemics of human" exact="immunodeficiency" post="virus (HIV) infection in China, particularly the globally available"/>
  <result pre="paper reviews the current epidemics of human immunodeficiency virus (HIV)" exact="infection" post="in China, particularly the globally available prevention strategies developed"/>
  <result pre="these prevention strategies can control the HIV epidemic. Keywords Human" exact="immunodeficiency" post="virus infection Epidemic Prevention strategies China Introduction The epidemic"/>
  <result pre="prevention strategies can control the HIV epidemic. Keywords Human immunodeficiency" exact="virus infection" post="Epidemic Prevention strategies China Introduction The epidemic of human"/>
  <result pre="strategies can control the HIV epidemic. Keywords Human immunodeficiency virus" exact="infection" post="Epidemic Prevention strategies China Introduction The epidemic of human"/>
  <result pre="can control the HIV epidemic. Keywords Human immunodeficiency virus infection" exact="Epidemic" post="Prevention strategies China Introduction The epidemic of human immunodeficiency"/>
  <result pre="infection Epidemic Prevention strategies China Introduction The epidemic of human" exact="immunodeficiency" post="virus (HIV) infection has changed remarkably around the world"/>
  <result pre="strategies China Introduction The epidemic of human immunodeficiency virus (HIV)" exact="infection" post="has changed remarkably around the world and domestically in"/>
  <result pre="over the past three decades, with a reduction in new" exact="infections" post="and improvements in both the treatment and prevention of"/>
  <result pre="using biological strategies, such as anti-retroviral therapy (ART) to achieve" exact="viral" post="suppression. Anti-retroviral medicines can now be used to eliminate"/>
  <result pre="such as male circumcision, have been widely used in some" exact="African" post="countries; while pre-exposure prophylaxis (PrEP) has been adopted in"/>
  <result pre="developed countries as national control strategies to reduce new HIV" exact="infections" post="among people at high-risk of HIV infection. In China,"/>
  <result pre="to reduce new HIV infections among people at high-risk of" exact="HIV infection." post="In China, HIV transmission via blood, including injecting drug"/>
  <result pre="China, HIV transmission via blood, including injecting drug use (the" exact="primary" post="transmission mode at the initial HIV epidemic stage) has"/>
  <result pre="transmission; however, accounted for about 95% of newly diagnosed HIV" exact="infections" post="in 2018.[9] Furthermore, there is no signal that the"/>
  <result pre="their feasibility to be adopted in China as national strategies." exact="General" post="Prevention Measures All prevention strategies are summarized in Table"/>
  <result pre="China, most of the public is familiar with HIV and" exact="acquired immune deficiency syndrome" post="(AIDS), even though they may not fully understand the"/>
  <result pre="of the public is familiar with HIV and acquired immune" exact="deficiency" post="syndrome (AIDS), even though they may not fully understand"/>
  <result pre="the public is familiar with HIV and acquired immune deficiency" exact="syndrome" post="(AIDS), even though they may not fully understand the"/>
  <result pre="campaign taught them about the risk of selling blood and" exact="HIV infection," post="promoting their need to get tested. In conjunction with"/>
  <result pre="messaging, the campaign mobilized different government entities to update national" exact="HIV/AIDS" post="policies and improve basic knowledge about HIV/AIDS. Since then,"/>
  <result pre="international groups such as the United Nations Jointed Program on" exact="HIV/AIDS" post="(UNAIDS) and United Nations Population Fund. Subsequently, public knowledge"/>
  <result pre="families is needed in China, as studies have found general" exact="lower" post="levels of HIV awareness within these groups.[13] Additionally, though"/>
  <result pre="to measure their effectiveness in reducing the number of HIV" exact="infections" post="or determining the changes in HIV knowledge in the"/>
  <result pre="HIV cases diagnosed at VCT sites accounted for 27% of" exact="total" post="diagnosed cases in China.[9] More importantly, the cases diagnosed"/>
  <result pre="giving them a chance to live longer, while also reducing" exact="secondary" post="HIV transmission in the community. PLWH who are unaware"/>
  <result pre="care settings has significantly increased, accounting for about 60% of" exact="total" post="tests and over 50% of diagnosed HIV cases throughout"/>
  <result pre="is relatively uncommon, accounting for a small proportion of HIV" exact="infections" post="around the world.[17] Having experienced an outbreak of HIV"/>
  <result pre="of HIV infectiousness, or the time between potential exposure to" exact="HIV infection" post="and when the HIV test will provide an accurate"/>
  <result pre="HIV infectiousness, or the time between potential exposure to HIV" exact="infection" post="and when the HIV test will provide an accurate"/>
  <result pre="use of these newer tests have reduced the risk of" exact="HIV infection" post="via blood transfusion by almost half. Challenges remain; as"/>
  <result pre="of these newer tests have reduced the risk of HIV" exact="infection" post="via blood transfusion by almost half. Challenges remain; as"/>
  <result pre="transfusion by almost half. Challenges remain; as sporadic cases of" exact="HIV infection" post="during this â€œwindow periodâ€� have been reported in China."/>
  <result pre="by almost half. Challenges remain; as sporadic cases of HIV" exact="infection" post="during this â€œwindow periodâ€� have been reported in China."/>
  <result pre="their blood may place recipients at a greater risk of" exact="HIV infection" post="if transfused during the window period. As more cases"/>
  <result pre="blood may place recipients at a greater risk of HIV" exact="infection" post="if transfused during the window period. As more cases"/>
  <result pre="are identified amongst donors, the higher chance of â€œwindow periodâ€�" exact="infections" post="and the higher the risk of HIV transmission via"/>
  <result pre="in 2006 to 0.03% in 2018, almost eliminating new HIV" exact="infections" post="amongst this group. The proportion of HIV cases acquired"/>
  <result pre="HIV infections amongst this group. The proportion of HIV cases" exact="acquired" post="via injecting drug use has also declined, from 44.2%"/>
  <result pre="result in increased condom use, leading to reduced sexually transmitted" exact="infections" post="(STIs) or HIV transmission.[27] Though efforts have been made"/>
  <result pre="sexual transmission. Since 2004, China has promoted condom use in" exact="female" post="sex workers and MSM for the prevention of HIV"/>
  <result pre="sexual episode.[29] From 2006 to 2015, the HIV prevalence among" exact="female" post="sex workers consistently remained below 1%, while the prevalence"/>
  <result pre="as â€œvertical transmission,â€� occurs when HIV is transmitted from an" exact="HIV-positive" post="mother to her child during pregnancy, childbirth, and breastfeeding."/>
  <result pre="their infants from acquiring HIV. More than one million HIV" exact="infections" post="among children have been prevented between 2010 and 2018"/>
  <result pre="Malaysia.[33] PMTCT is also a key component of China's national" exact="HIV/AIDS" post="strategy. In 2005, China started its first PMTCT program"/>
  <result pre="HIV testing and treatment as a standardized part of HIV" exact="antenatal" post="care.[34] China's Integrated Prevention of Mother-to-Child Transmission of HIV,"/>
  <result pre="China's Integrated Prevention of Mother-to-Child Transmission of HIV, Syphilis, and" exact="Hepatitis" post="B program was later launched in 2010 and extended"/>
  <result pre="HIV. Since implementing the PMTCT program, HIV testing rates among" exact="HIV-positive" post="mothers and the number receiving ART have both increased,"/>
  <result pre="collaboration efforts and quality of services are needed to achieve" exact="total" post="elimination of mother-to-child transmission in China. Newly Developed Prevention"/>
  <result pre="as the year 2000, researchers have found that when HIV" exact="viral" post="load was lower than 400 copies per milliliters, the"/>
  <result pre="2000, researchers have found that when HIV viral load was" exact="lower" post="than 400 copies per milliliters, the virus was not"/>
  <result pre="to gain notoriety.[37] Additional trials have also reported that when" exact="viral" post="load was reduced to undetectable levels, the HIV transmission"/>
  <result pre="place great importance on promoting good adherence and monitoring of" exact="viral" post="load among those initiating treatment. 90-90-90 strategies Theoretical, mathematical"/>
  <result pre="modeling studies have shown that once the proportion of HIV" exact="infections" post="diagnosed, treated, and achieving viral suppression reaches a certain"/>
  <result pre="once the proportion of HIV infections diagnosed, treated, and achieving" exact="viral" post="suppression reaches a certain level, the HIV epidemic may"/>
  <result pre="that when coverage of ART is high, the incidence of" exact="HIV infection" post="is low.[42] Therefore, in 2014, the UNAIDS announced a"/>
  <result pre="when coverage of ART is high, the incidence of HIV" exact="infection" post="is low.[42] Therefore, in 2014, the UNAIDS announced a"/>
  <result pre="of diagnosed PLWH receive ART, and 90% receiving ART achieve" exact="viral" post="suppression.[43] The 90-90-90 strategy has been adopted by many"/>
  <result pre="is not constant across regions; however, particularly in Western and" exact="Central" post="Africa and the Middle East and North Africa, where"/>
  <result pre="HIV among MSM communities in China. Detection and treatment of" exact="acute" post="infection HIV progression can be divided into the following"/>
  <result pre="among MSM communities in China. Detection and treatment of acute" exact="infection" post="HIV progression can be divided into the following stages:"/>
  <result pre="infection HIV progression can be divided into the following stages:" exact="acute" post="infection, asymptomatic phase, and clinical symptomatic phase. Individuals experience"/>
  <result pre="into the following stages: acute infection, asymptomatic phase, and clinical" exact="symptomatic" post="phase. Individuals experience different levels of infectiousness depending on"/>
  <result pre="HIV at the community level.[50] Additionally, individuals at the early," exact="acute" post="stage of HIV tend to have high viral load"/>
  <result pre="the early, acute stage of HIV tend to have high" exact="viral" post="load and be very infectious. Acute infection can be"/>
  <result pre="tend to have high viral load and be very infectious." exact="Acute" post="infection can be defined as the period between HIV"/>
  <result pre="to have high viral load and be very infectious. Acute" exact="infection" post="can be defined as the period between HIV acquisition"/>
  <result pre="of increased transmission efficiency. Thus, immediate diagnosis and treatment of" exact="acute" post="HIV infection can significantly reduce new cases of HIV."/>
  <result pre="increased transmission efficiency. Thus, immediate diagnosis and treatment of acute" exact="HIV infection" post="can significantly reduce new cases of HIV. Optimal clinical"/>
  <result pre="transmission efficiency. Thus, immediate diagnosis and treatment of acute HIV" exact="infection" post="can significantly reduce new cases of HIV. Optimal clinical"/>
  <result pre="cases of HIV. Optimal clinical and public health strategies for" exact="acute" post="infection are lacking; however. There are currently not specific"/>
  <result pre="of HIV. Optimal clinical and public health strategies for acute" exact="infection" post="are lacking; however. There are currently not specific guidelines"/>
  <result pre="specific guidelines regarding diagnostic strategies or ART for persons with" exact="acute" post="infection in China. This is particularly worrisome, as acute"/>
  <result pre="guidelines regarding diagnostic strategies or ART for persons with acute" exact="infection" post="in China. This is particularly worrisome, as acute infection"/>
  <result pre="with acute infection in China. This is particularly worrisome, as" exact="acute" post="infection may compromise the effectiveness of PrEP.[51] Early treatment"/>
  <result pre="acute infection in China. This is particularly worrisome, as acute" exact="infection" post="may compromise the effectiveness of PrEP.[51] Early treatment initiation"/>
  <result pre="can avert damage to the immune system and shrink latent" exact="viral" post="reservoirs.[51] Kroon and colleagues, for example, found that diagnosis"/>
  <result pre="and colleagues, for example, found that diagnosis and treatment of" exact="acute" post="HIV infection among the MSM community could reduce 88%"/>
  <result pre="colleagues, for example, found that diagnosis and treatment of acute" exact="HIV infection" post="among the MSM community could reduce 88% of new"/>
  <result pre="for example, found that diagnosis and treatment of acute HIV" exact="infection" post="among the MSM community could reduce 88% of new"/>
  <result pre="could reduce 88% of new HIV infections.[52] The period of" exact="acute" post="HIV infection, however, is very short and its role"/>
  <result pre="reduce 88% of new HIV infections.[52] The period of acute" exact="HIV infection," post="however, is very short and its role in HIV"/>
  <result pre="infections.[52] The period of acute HIV infection, however, is very" exact="short" post="and its role in HIV transmission is limited.[53] In"/>
  <result pre="role in HIV transmission is limited.[53] In addition, diagnosis of" exact="acute" post="HIV infection is very difficult and hard to implement"/>
  <result pre="in HIV transmission is limited.[53] In addition, diagnosis of acute" exact="HIV infection" post="is very difficult and hard to implement in many"/>
  <result pre="HIV transmission is limited.[53] In addition, diagnosis of acute HIV" exact="infection" post="is very difficult and hard to implement in many"/>
  <result pre="the use of PrEP globally. PrEP works by stopping the" exact="viral" post="replication of HIV and if used consistently, can overwhelmingly"/>
  <result pre="drugs,[60] the daily use tenofovir disoproxil fumarate/emtricitabine can significantly reduce" exact="HIV infection," post="potentially preventing 90% of infections. In MSM, studies have"/>
  <result pre="HIV, with research showing it can reduce the risk of" exact="infection" post="by 80%.[66] In Nigeria, an observational study observed that"/>
  <result pre="were exposed to HIV over a 12-year period, no single" exact="HIV infection" post="was transmitted when the professionals took PEP.[67] In China,"/>
  <result pre="exposed to HIV over a 12-year period, no single HIV" exact="infection" post="was transmitted when the professionals took PEP.[67] In China,"/>
  <result pre="has been used in a timely manner and no single" exact="HIV infection" post="has been reported.[68] National and international guidelines regarding PEP"/>
  <result pre="been used in a timely manner and no single HIV" exact="infection" post="has been reported.[68] National and international guidelines regarding PEP"/>
  <result pre="suggested that medical male circumcision can reduce the risk of" exact="female" post="to male sexual transmission by approximately 60%.[71] Thus for"/>
  <result pre="has primarily been used and found to be effective in" exact="African" post="countries,[72] though studies have reported varying outcomes relating to"/>
  <result pre="male circumcision was associated with a 24% decreased odds of" exact="HIV infection" post="among MSM in low and middle-income countries.[74] With support"/>
  <result pre="circumcision was associated with a 24% decreased odds of HIV" exact="infection" post="among MSM in low and middle-income countries.[74] With support"/>
  <result pre="the Major Research Project on Prevention and Treatment of Major" exact="Infectious" post="Diseases including AIDS and Viral Hepatitis, China has pilot-tested"/>
  <result pre="Major Research Project on Prevention and Treatment of Major Infectious" exact="Diseases" post="including AIDS and Viral Hepatitis, China has pilot-tested male"/>
  <result pre="Prevention and Treatment of Major Infectious Diseases including AIDS and" exact="Viral" post="Hepatitis, China has pilot-tested male circumcision among MSM. Unfortunately,"/>
  <result pre="found to be very low.[64] Given very low prevalence of" exact="HIV infection," post="about eight per ten thousand, we do not believe"/>
  <result pre="ART drug Dapivirine, provided a modest level of protection against" exact="HIV infection" post="in women.[75] Similar trials testing the safety and efficacy"/>
  <result pre="drug Dapivirine, provided a modest level of protection against HIV" exact="infection" post="in women.[75] Similar trials testing the safety and efficacy"/>
  <result pre="been focused on pre-clinical development, addressing the mechanism of mucosal" exact="HIV infection," post="though few outcomes have thus far been reported. Microbicides"/>
  <result pre="Vaccine A vaccine is the most effective strategy to controlling" exact="viral" post="infectious epidemics. However, 35 years have passed since the"/>
  <result pre="A vaccine is the most effective strategy to controlling viral" exact="infectious" post="epidemics. However, 35 years have passed since the first"/>
  <result pre="The RV 144 trial performed in Thailand found that the" exact="HIV infection" post="rate was 31.2% lower in the group receiving the"/>
  <result pre="RV 144 trial performed in Thailand found that the HIV" exact="infection" post="rate was 31.2% lower in the group receiving the"/>
  <result pre="in Thailand found that the HIV infection rate was 31.2%" exact="lower" post="in the group receiving the vaccine compared to the"/>
  <result pre="placebo.[76] Though efforts to find an effective vaccine for preventing" exact="HIV infection" post="continue, there remain great challenges given the rapid mutation"/>
  <result pre="Though efforts to find an effective vaccine for preventing HIV" exact="infection" post="continue, there remain great challenges given the rapid mutation"/>
  <result pre="years. Conclusions Sexual transmission of HIV accounts for 95% of" exact="infections" post="in China, with the number of newly diagnosed cases"/>
  <result pre="can be used alone to stop the epidemic. Cases in" exact="African" post="countries or parts of China have demonstrated that implementation"/>
  <result pre="sexual transmission of HIV, should focus on three critical areas:" exact="infectious" post="cases, transmission mode, and the susceptible population. Prevention must"/>
  <result pre="strategies in targeted populations can the number of new HIV" exact="infections" post="be reduced. Disclaimer The views and opinions expressed herein"/>
  <result pre="and Technology Major Project on Prevention and Treatment of Major" exact="Infectious" post="Diseases Including AIDS and Viral Hepatitis (No. 2012ZX10001-007) Conflicts"/>
  <result pre="Technology Major Project on Prevention and Treatment of Major Infectious" exact="Diseases" post="Including AIDS and Viral Hepatitis (No. 2012ZX10001-007) Conflicts of"/>
  <result pre="Prevention and Treatment of Major Infectious Diseases Including AIDS and" exact="Viral" post="Hepatitis (No. 2012ZX10001-007) Conflicts of interest None. How to"/>
  <result pre="and Treatment of Major Infectious Diseases Including AIDS and Viral" exact="Hepatitis" post="(No. 2012ZX10001-007) Conflicts of interest None. How to cite"/>
  <result pre="How to cite this article: Wu ZY, Scott SR. Human" exact="immunodeficiency" post="virus prevention strategies in China. Chin Med J 2020;133:318â€&quot;325."/>
  <result pre="China. Chin Med J 2020;133:318â€&quot;325. doi: 10.1097/CM9.0000000000000647 References References 1.WuZRouKCuiHThe" exact="HIV/AIDS" post="epidemic in China: history, current strategies and future challenges."/>
  <result pre="overview of the history of epidemic of and response to" exact="HIV/AIDS" post="in China: achievements and challenges. Chin Med J2009; 122:2251â€&quot;2257."/>
  <result pre="regional, and national incidence and mortality for HIV, tuberculosis, and" exact="malaria" post="during 1990â€&quot;2013: a systematic analysis for the Global Burden"/>
  <result pre="during 1990â€&quot;2013: a systematic analysis for the Global Burden of" exact="Disease" post="Study 2013. Lancet2014; 384:1005â€&quot;1070. doi: 10.1016/S0140-6736(14)60844-8.25059949 5.collab: GBD 2015"/>
  <result pre="prevalence, and mortality of HIV, 1980â€&quot;2015: the Global Burden of" exact="Disease" post="Study 2015. Lancet HIV2016; 3:e361â€&quot;e387. doi: 10.1016/S0140-6736(16)31012-1.27470028 6.ZhaoYPoundstoneKEMontanerJWuZYNew policies"/>
  <result pre="HIV2016; 3:e361â€&quot;e387. doi: 10.1016/S0140-6736(16)31012-1.27470028 6.ZhaoYPoundstoneKEMontanerJWuZYNew policies and strategies to tackle" exact="HIV/AIDS" post="in China. Chin Med J (Engl)2012; 125:1331â€&quot;1337. doi: 10.3760/cma.j.issn.0366-6999.2012.07.025.22613610"/>
  <result pre="preexposure prophylaxis: a review. JAMA2018; 319:1261â€&quot;1268. doi: 10.1001/jama.2018.1917.29584848 8.CuiYShiCXWuZEpidemiology of" exact="HIV/AIDS" post="in China: recent trends. Global Health J2017; 1:26â€&quot;32. 10.1016/S2414-6447(19)30057-0"/>
  <result pre="HIV/AIDS. Lancet2007; 369:679â€&quot;690. doi: 10.1016/S0140-6736(07)60315-8.17321313 13.LiuHLiMJinMJingFWangHChenKPublic awareness of three major" exact="infectious diseases" post="in rural Zhejiang province, China: a cross-sectional study. BMC"/>
  <result pre="10.1186/1471-2334-13-192.23627258 14.collab: Humana People to People China. Progress reports in" exact="infectious disease" post="control in Yuexi, Sichuan Province. Available from: http://www.hppchina.org.cn/article/index/index/?lang=Cn&amp;amp;id=273. [Accessed"/>
  <result pre="14.collab: Humana People to People China. Progress reports in infectious" exact="disease" post="control in Yuexi, Sichuan Province. Available from: http://www.hppchina.org.cn/article/index/index/?lang=Cn&amp;amp;id=273. [Accessed"/>
  <result pre="Immune Defic Syndr2009; 52: Suppl 2: S127â€&quot;S131. doi: 10.1097/QAI.0b013e3181baf0ac.19901625 18.WuZLiuZDetelsRHIV-1" exact="infection" post="in commercial plasma donors in China. Lancet1995; 346:61â€&quot;62. doi:"/>
  <result pre="plasma donors in China. Lancet1995; 346:61â€&quot;62. doi: 10.1016/s0140-6736(95)92698-4. 19.WuZRouKDetelsRPrevalence of" exact="HIV infection" post="among former commercial plasma donors in rural eastern China."/>
  <result pre="donors in China. Lancet1995; 346:61â€&quot;62. doi: 10.1016/s0140-6736(95)92698-4. 19.WuZRouKDetelsRPrevalence of HIV" exact="infection" post="among former commercial plasma donors in rural eastern China."/>
  <result pre="men with self-deferral from blood donation in a Chinese population." exact="Blood" post="Transfus2014; 12:166â€&quot;171. doi: 10.2450/2013.0103-13.24333076 22.LuJXuJReillyKHLiYZhangCMJiangYet al.The proportion and trend"/>
  <result pre="12:166â€&quot;171. doi: 10.2450/2013.0103-13.24333076 22.LuJXuJReillyKHLiYZhangCMJiangYet al.The proportion and trend of human" exact="immunodeficiency" post="virus infections associated with men who have sex with"/>
  <result pre="10.2450/2013.0103-13.24333076 22.LuJXuJReillyKHLiYZhangCMJiangYet al.The proportion and trend of human immunodeficiency virus" exact="infections" post="associated with men who have sex with men from"/>
  <result pre="for high-risk sexual behavior. Transfusion2011; 51:1829â€&quot;1834. doi: 10.1111/j.1537-2995.2011.03078.x.21382047 24.PetersPJPontonesPHooverKWPatelMRGalangRRShieldsJet al.HIV" exact="infection" post="linked to injection use of oxymorphone in Indiana, 2014â€&quot;2015."/>
  <result pre="meta-analysis. PloS One2014; 9:e111175doi: 10.1371/journal.pone.0111175.25369471 31.ChenXSPeelingRWYinYPMabeyDCThe epidemic of sexually transmitted" exact="infections" post="in China: implications for control and future perspectives. BMC"/>
  <result pre="doi: 10.1136/sextrans-2014-051877.25935929 35.WangAQiaoYDouLWangQWangXSuMet al.Challenges of eliminating mother-to-child transmission of HIV," exact="syphilis" post="and hepatitis B in China: a cross-sectional survey. Poster"/>
  <result pre="35.WangAQiaoYDouLWangQWangXSuMet al.Challenges of eliminating mother-to-child transmission of HIV, syphilis and" exact="hepatitis" post="B in China: a cross-sectional survey. Poster Abstract. Lancet,"/>
  <result pre="21, 2019. 36.QuinnTCWawerMJSewankamboNSerwaddaDLiCWabwire-MangenFet al.Viral load and heterosexual transmission of human" exact="immunodeficiency" post="virus type 1. Rakai Project Study Group. N Engl"/>
  <result pre="36.QuinnTCWawerMJSewankamboNSerwaddaDLiCWabwire-MangenFet al.Viral load and heterosexual transmission of human immunodeficiency virus" exact="type 1." post="Rakai Project Study Group. N Engl J Med2000; 342:921â€&quot;929."/>
  <result pre="Engl J Med2000; 342:921â€&quot;929. doi: 10.1056/NEJM200003303421303.10738050 37.CohenMSChenYQMcCauleyMGambleTHosseinipourMCKumarasamyNet al.Prevention of HIV-1" exact="infection" post="with early antiretroviral therapy. N Engl J Med2011; 365:493â€&quot;505."/>
  <result pre="and risk of HIV transmission in serodifferent couples when the" exact="HIV-positive" post="partner is using suppressive antiretroviral therapy. JAMA2016; 316:171â€&quot;181. doi:"/>
  <result pre="2019. 45.MontanerJSLimaVDBarriosRYipBWoodEKerrTet al.Association of highly active antiretroviral therapy coverage, population" exact="viral" post="load, and yearly new HIV diagnoses in British Columbia,"/>
  <result pre="Canada: a population-based study. Lancet2010; 376:532â€&quot;539. doi: 10.1016/S0140-6736(10)60936-1.20638713 46.MaYDouZGuoWMaoYZhangFMcGooganJMThe human" exact="immunodeficiency" post="virus care continuum in China: 1985-2015. Clin Infect Dis2018;"/>
  <result pre="2.0 interventions to address the HIV continuum of care. Curr" exact="HIV/AIDS" post="Rep2015; 12:173â€&quot;190. doi: 10.1007/s11904-014-0239-3.25626718 49.Hightow-WeidmanLBMuessigKEBauermeisterJALeGrandSFiellinLEThe future of digital games"/>
  <result pre="Opin HIV AIDS2017; 12:501â€&quot;507. doi: 10.1097/COH.0000000000000399.28692490 50.PowersKAGhaniACMillerWCHoffmanIFPettiforAEKamangaGet al.The role of" exact="acute" post="and early HIV infection in the spread of HIV"/>
  <result pre="12:501â€&quot;507. doi: 10.1097/COH.0000000000000399.28692490 50.PowersKAGhaniACMillerWCHoffmanIFPettiforAEKamangaGet al.The role of acute and early" exact="HIV infection" post="in the spread of HIV and implications for transmission"/>
  <result pre="doi: 10.1097/COH.0000000000000399.28692490 50.PowersKAGhaniACMillerWCHoffmanIFPettiforAEKamangaGet al.The role of acute and early HIV" exact="infection" post="in the spread of HIV and implications for transmission"/>
  <result pre="378:256â€&quot;268. doi: 10.1016/S0140-6736(11)60842-8.21684591 51.RutsteinSEAnanworanichJFidlerSJohnsonCSandersEJSuedOet al.Clinical and public health implications of" exact="acute" post="and early HIV detection and treatment: a scoping review."/>
  <result pre="scoping review. J Int AIDS Soc2017; 20:21579doi: 10.7448/IAS.20.1.21579.28691435 52.KroonEPhanuphakNShattockAJFletcherJLKPinyakornSChomcheyNet al.Acute" exact="HIV infection" post="detection and immediate treatment estimated to reduce transmission by"/>
  <result pre="review. J Int AIDS Soc2017; 20:21579doi: 10.7448/IAS.20.1.21579.28691435 52.KroonEPhanuphakNShattockAJFletcherJLKPinyakornSChomcheyNet al.Acute HIV" exact="infection" post="detection and immediate treatment estimated to reduce transmission by"/>
  <result pre="Bangkok. J Int AIDS Soc2017; 20:21708doi: 10.7448/IAS.20.1.21708.28691441 53.SutharABGranichRMKatoMNsanzimanaSMontanerJSWilliamsBGProgrammatic implications of" exact="acute" post="and early HIV infection. J Infect Dis2015; 212:1351â€&quot;1360. doi:"/>
  <result pre="AIDS Soc2017; 20:21708doi: 10.7448/IAS.20.1.21708.28691441 53.SutharABGranichRMKatoMNsanzimanaSMontanerJSWilliamsBGProgrammatic implications of acute and early" exact="HIV infection." post="J Infect Dis2015; 212:1351â€&quot;1360. doi: 10.1093/infdis/jiv430.26310309 54.MarcusJLHurleyLBHareCBNguyenDPPhengrasamyTSilverbergMJet al.Preexposure prophylaxis"/>
  <result pre="10.1056/NEJMoa1011205.21091279 56.McCormackSDunnDTDesaiMDollingDIGafosMGilsonRet al.Pre-exposure prophylaxis to prevent the acquisition of HIV-1" exact="infection" post="(PROUD): effectiveness results from the pilot phase of a"/>
  <result pre="N Engl J Med2012; 367:423â€&quot;434. doi: 10.1056/NEJMoa1110711.22784038 60.ChoopanyaKMartinMSuntharasamaiPSangkumUMockPALeethochawalitMAntiretroviral prophylaxis for" exact="HIV infection" post="in injecting drug users in Bangkok, Thailand (the Bangkok"/>
  <result pre="Engl J Med2012; 367:423â€&quot;434. doi: 10.1056/NEJMoa1110711.22784038 60.ChoopanyaKMartinMSuntharasamaiPSangkumUMockPALeethochawalitMAntiretroviral prophylaxis for HIV" exact="infection" post="in injecting drug users in Bangkok, Thailand (the Bangkok"/>
  <result pre="10.1016/S0140-6736(13)61127-7.23769234 61.ZongXPractice and challenges in pre-exposure prophylaxis research to prevent" exact="HIV infection." post="A presentation made at 2018 Academic Conference of National"/>
  <result pre="doi: 10.1007/s40265-015-0355-4.25673022 66.collab: World Health Organization. Post-exposure prophylaxis to prevent" exact="HIV infection." post="Fact sheet - 1 December 2014. https://www.who.int/hiv/topics/prophylaxis/info/en/Accessed on December"/>
  <result pre="67.AbubakarSIliyasuGDayyabFMInuwaSTudun WadaRASadiqNMet al.Post-exposure prophylaxis following occupational exposure to HIV and" exact="hepatitis" post="B: an analysis of a 12-year record in a"/>
  <result pre="J Infect Prev2018; 19:184â€&quot;189. doi: 10.1177/1757177417746733.30013623 68.MaCQiuMWuZWYDetelsRButerysMMcGooganJMPreventing occupational exposure. Springer," exact="HIV/AIDS" post="in China- Epidemiology, Prevention and Treatment. Singapore: 2019. 69.BennPFisherMKulasegaramRUK"/>
  <result pre="21, 2019. 72.WamburaMMahlerHGrundJMLarkeNMshanaGKuringeEet al.Increasing voluntary medical male circumcision uptake among" exact="adult" post="men in Tanzania. AIDS2017; 31:1025â€&quot;1034. doi: 10.1097/QAD.0000000000001440.28350578 73.GoodreauSMCarnegieNBVittinghoffELarkeNMshanaGKuringeEet al.Can"/>
  <result pre="pone.0102960.25076493 74.YuanTFitzpatrickTKoNYCaiYChenYZhaoJet al.Circumcision to prevent HIV and other sexually transmitted" exact="infections" post="in men who have sex with men: a systematic"/>
  <result pre="76.Rerks-NgarmSPitisuttithumPNitayaphanSKaewkungwalJJoseph ChiuJParisRet al.Vaccination with ALVAC and AIDSVAX to Prevent HIV-1" exact="Infection" post="in Thailand. N Engl J Med2009; 361:2209â€&quot;2220. doi: 10.1056/NEJMoa0908492.19843557"/>
 </snippets>
</snippetsTree>
